Postoperative chemoradiotherapy of pancreatic cancer: What is the appropriate target volume of radiation therapy?

Tumori

Volumn 91, Issue 6, 2005, Pages 493-497

  Kim, Kyubo ^a   Kim, Suzy ^a   Chie, Eui Kyu ^a   Kim, Sun Whe ^a   Bang, Yung Jue ^a   Ha, Sung W ^a,b  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Adjuvant therapy; Chemoradiotherapy; Pancreatic cancer; Target volume

Indexed keywords

FLUOROURACIL;

ABDOMINAL PAIN; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; DIARRHEA; EVALUATION RESEARCH; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PANCREAS CANCER; PANCREAS RESECTION; PANCREATICODUODENECTOMY; PARAAORTIC LYMPH NODE; POSTOPERATIVE PERIOD; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR VOLUME; VOMITING;

EID: 32844462059     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160509100609     Document Type: Article

References (22)

1. Neoptolemos JP: Adjuvant radiotherapy and follow on chemotherapy in patients with pancreatic cancer: results of the UK Pancreatic Cancer Study Group (UKPACA-1). GI Cancer, 2: 235-245, 1998.
2. Regiene WF, Abrams RA: Adjuvant therapy for pancreatic cancer: back to the future. Int J Radiat Oncol Biol Phys, 42: 59-63, 1998.
3. Ghaneh P, Slavin J, Sutton R, Hartley M, Neoptolemos JP: Adjuvant therapy in pancreatic cancer. World J Gastroenterol, 7: 482-489, 2001.
4. Kalser MH, Ellenberg SS: Pancreatic cancer: Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg, 120: 899-903, 1985.
5. Neoptolemos JP, Dunn JA, Stocken DD, Almond J, Link K, Beger H, Bassi C, Falconi M, Pederzoli P, Dervenis C, Fernandez-Cruz L, Lacaine F, Pap A, Spooner D, Kerr DJ, Friess H, Buchler MW: Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet, 358: 1576-1585, 2001.
6. Klinkenbijl JH, Jeekel J, Sahmoud T, van Pel R, Couvreur ML, Veenhof CH, Arnaud JP, Gonzalez DG, de Wit LT, Hennipman A, Wils J: Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region. Ann Surg, 230: 776-784, 1999.
7. Kaplan EL, Meier PI: A nonparametric estimation from incomplete observations. J Am Statics Assoc, 53: 457-481, 1958.
8. Herrmann T, Knorr A, Dorner K: The RTOG/EORTC classification criteria for early and late radiation reactions. Radiobiol Radiother (Berl), 8: 519-528, 1987.
9. Douglass HO: Further evidence of effective adjuvant combined radiation and hemotherapy following curative resection of pancreatic cancer. Cancer, 59: 2006-2010, 1987.
10. Paulino AC: Resected pancreatic cancer treated with adjuvant radiotherapy with or without 5-fluorouracil: Treatment results and patterns of failure. Am J Clin Oncol (CCT), 22: 489-494, 1999.
11. Foo ML, Gunderson LL, Nagorney DM, McLlrath DC, van Heerden JA, Robinow JS, Kvols LK, Garton GR, Martenson JA, Cha SS: Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation ± 5-fluorouracil. Int J Radiat Oncol Biol Phys, 26: 483-489, 1993.
12. Okamoto A, Tsuruta K, Karasawa K, Miyanari N, Matsumoto G, Kamisawa T, Egawa N: Resection versus palliation: treatment of stage III or IVA carcinomas of pancreas employing intraoperative radiation. World J Surg, 27: 599-605, 2003.
13. Cascinu S, Silva RR, Barni S, Labianca R, Frontini L, Piazza E, Pancera G, Giordani P, Giuliodori L, Pessi MA, Fusco V, Luporini G, Cellerino R, Catalano G: A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of digestive Tract Cancer (GISCAD). Br J Cancer, 80: 1595-1598, 1999.
14. Hidalgo M, Castellano D, Paz-Ares L, Gravalos C, Diaz-Puente M, Hitt R, Alonso S, Cortes-Funes H: Phase I-II study of gemcitabine and fluorouracil as a continuous infusion in patients with pancreatic cancer. J Clin Oncol, 17: 585-592, 1999.
15. Heinemann V, Wilke H, Mergenthaler HG, Clemens M, Konig H, Illiger HJ, Arning M, Schalhorn A, Possinger K, Fink U: Gemcitabine and cisplatin in the treatment of advanced or metastatic pancreatic cancer. Ann Oncol, 11: 1399-1403, 2000.
16. Colucci G, Riccardi F, Giuliani F, Lopez M, Gebbia V, Uomo G, Biglietto M, Cigolari S, Borsellino N, Paoletti G, Maiello E, Gebbia N: Radomized trial of gemcitabine alone or with cisplatin in advanced pancreatic cancer: a phase II multicenter study of the Southern Italy Oncology Group. Proc Am Soc Clin Oncol, 18: 250a (abst), 1999.
17. Scheithauer W, Kornek GV, Raderer M, Hejna M, Valencak J, Miholic J, Kovats E, Lang F, Funovics J, Bareck E, Depisch D: Phase II trial of gemcitabine, epirubicin and granlocyte colony-stimulating factor in patients with advanced pancreatic adnocarcinoma. Br J Cancer, 80: 1797-1802, 1999.
18. Burris HA 3rd, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, Cripps MC, Portenoy RK, Storniolo AM, Tarassoff P, Nelson R, Dorr FA, Stephens CD, Von Hoff DD: Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol, 15: 2403-2413, 1997.
19. Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, Hickey H, Beger H, Fernandez-Cruz L, Dervenis C, Lacaine F, Falconi M, Pederzoli P, Pap A, Spooner D, Kerr DJ, Buchler MW: A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med, 350: 1200-1210, 2004.
20. Allen AM, Zalupski MM, Robertson JM, Eckhauser FE, Simone D, Brown D, Hejna G, Normolle D, Lawrence TS, McGinn CJ: Adjuvant therapy in pancreatic cancer: Phase I trial of radiation dose escalation with concurrent full-dose gemcitabine. Int J Radiat Oncol Biol Phys, 59: 1461-1467, 2004.
21. Ben-Josef E, Schields AF, Vaishampayan U, Vaitkevicius V, El-Rayes BF, McDermott P, Burmeister J, Bossenberger T, Philip PA: Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer. Int J Radiat Oncol Biol Phys, 59: 454-459, 2004.
22. Milano MT, Chmura SJ, Garofalo MC, Rash C, Roeske JC, Connell PP, Kwon OH, Jani AB, Heimann R: Intensity-modulated radiotherapy in treatment of pancreatic and bile duct malignancies: toxicity and clinical outcome. Int J Radiat Oncol Biol Phys, 59: 445-453, 2004.